Guangzhou Lianao Network Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Guangzhou Lianao Network Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include MUSCAO. The owner is based in Guangzhou, Guangdong.

YE 08 Room 1929, No.518, Tianhe Road

Guangzhou, Guangdong 510000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

MUSCAO
MUSCAO
Registered 2021

Trademark Classifications

Guangzhou Lianao Network Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Guangzhou Lianao Network Technology Co., Ltd. have?

Guangzhou Lianao Network Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Guangzhou Lianao Network Technology Co., Ltd. file in?

Guangzhou Lianao Network Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Guangzhou Lianao Network Technology Co., Ltd.'s most well-known trademarks?

Guangzhou Lianao Network Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as MUSCAO. These are among 1 currently registered trademark in the portfolio.

What is Guangzhou Lianao Network Technology Co., Ltd.'s trademark registration success rate?

Guangzhou Lianao Network Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.